In this issue:
COMBO-MS: CBT + modafinil for MS fatigue
EvolutionRMS1 & 2: evobrutinib vs. teriflunomide in relapsing MS
Real-world ocrelizumab vs. ofatumumab in MS
Misapplication of McDonald criteria in Germany
Natalizumab & CSF OCBs in MS
Routine CSF parameters predictive of RRMS disease course
LemKids: alemtuzumab in paediatric RRMS
Dimethyl fumarate during pregnancy
Ocrelizumab during pregnancy
Switch from natalizumab to antiCD20: transition interval length
Please login below to download this issue (PDF)